Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Moon

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Journal of Diabetes and Its Complications|August 27, 2020
Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetesJeff Y Yang, Andrew M Moon, Hannah Kim, et al.
Gastroenterology|February 23, 2019
ReplyAndrew M Moon, Noel S Weiss, Lauren A Beste, et al.
Gastroenterology|July 9, 2018
No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With CirrhosisAndrew M Moon, Noel S Weiss, Lauren A Beste, et al.
Hepatology (Baltimore, Md.)|December 15, 2025
Hepatocellular carcinoma with macrovascular invasion: Review and survival meta-analysis of initial local therapy using minimal prognostic criteriaMarta Fortuny, Antonio De Rosa, Ignacio Roca, et al.
American Journal of Public Health|May 26, 2022
Robust Hepatitis A Vaccination Response Within the United States Veterans Health Administration in the Wake of State OutbreaksAndrew M Moon, Joleen A Borgerding, Ronald G Hauser, et al.
BMC Gastroenterology|February 28, 2024
Scoping review of values elicitation tools for treatment decisions in hepatocellular carcinomaGabrielle Ritaccio, A Sidney Barritt Iv, Jamie L Conklin, et al.
Hepatology Communications|October 7, 2020
A Systematic Review of Patient-Reported Outcomes in Primary Biliary Cholangitis and Primary Sclerosing CholangitisHannah P Kim, Sarah R Lieber, Michael E Rogers, et al.
Cancer Medicine|February 15, 2026
Less Restrictive Medicaid Policies for Direct-Acting Antiviral Access Are Associated With Greater Declines in Hepatocellular Carcinoma DeathsGabriel V Lupu, Bhagyashree Behera, A Sidney Barritt, et al.
Digestive Diseases and Sciences|May 19, 2026
External Validation of Laboratory-Based Models to Assess Portal Hypertension Severity in Patients with Compensated Chronic Liver DiseaseFahad S Mohammed, Minzhi Xing, Michael Mohnasky, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 16, 2021
SARS-CoV-2 in Pediatric Liver Transplant Recipients: The European ExperienceGustav Buescher, Marcial Sebode, Thomas Marjot, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Journal of Diabetes and Its Complications|August 27, 2020
Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetesJeff Y Yang, Andrew M Moon, Hannah Kim, et al.
Gastroenterology|February 23, 2019
ReplyAndrew M Moon, Noel S Weiss, Lauren A Beste, et al.
Gastroenterology|July 9, 2018
No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With CirrhosisAndrew M Moon, Noel S Weiss, Lauren A Beste, et al.
Hepatology (Baltimore, Md.)|December 15, 2025
Hepatocellular carcinoma with macrovascular invasion: Review and survival meta-analysis of initial local therapy using minimal prognostic criteriaMarta Fortuny, Antonio De Rosa, Ignacio Roca, et al.
American Journal of Public Health|May 26, 2022
Robust Hepatitis A Vaccination Response Within the United States Veterans Health Administration in the Wake of State OutbreaksAndrew M Moon, Joleen A Borgerding, Ronald G Hauser, et al.
BMC Gastroenterology|February 28, 2024
Scoping review of values elicitation tools for treatment decisions in hepatocellular carcinomaGabrielle Ritaccio, A Sidney Barritt Iv, Jamie L Conklin, et al.
Hepatology Communications|October 7, 2020
A Systematic Review of Patient-Reported Outcomes in Primary Biliary Cholangitis and Primary Sclerosing CholangitisHannah P Kim, Sarah R Lieber, Michael E Rogers, et al.
Cancer Medicine|February 15, 2026
Less Restrictive Medicaid Policies for Direct-Acting Antiviral Access Are Associated With Greater Declines in Hepatocellular Carcinoma DeathsGabriel V Lupu, Bhagyashree Behera, A Sidney Barritt, et al.
Digestive Diseases and Sciences|May 19, 2026
External Validation of Laboratory-Based Models to Assess Portal Hypertension Severity in Patients with Compensated Chronic Liver DiseaseFahad S Mohammed, Minzhi Xing, Michael Mohnasky, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 16, 2021
SARS-CoV-2 in Pediatric Liver Transplant Recipients: The European ExperienceGustav Buescher, Marcial Sebode, Thomas Marjot, et al.
Pageof 11